These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 24316906)

  • 41. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.
    Magnusson K; de Wit M; Brennan DJ; Johnson LB; McGee SF; Lundberg E; Naicker K; Klinger R; Kampf C; Asplund A; Wester K; Gry M; Bjartell A; Gallagher WM; Rexhepaj E; Kilpinen S; Kallioniemi OP; Belt E; Goos J; Meijer G; Birgisson H; Glimelius B; Borrebaeck CA; Navani S; Uhlén M; O'Connor DP; Jirström K; Pontén F
    Am J Surg Pathol; 2011 Jul; 35(7):937-48. PubMed ID: 21677534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
    Giannico GA; Gown AM; Epstein JI; Revetta F; Bishop JA
    Hum Pathol; 2017 Sep; 67():152-159. PubMed ID: 28711650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
    Sangoi AR; Kshirsagar M; Horvai AE; Roma AA
    Int J Gynecol Pathol; 2017 Mar; 36(2):140-145. PubMed ID: 27294605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Study progress of special AT-rich sequence binding protein 2].
    Qian YY; Wang HJ; Ma D
    Yi Chuan; 2011 Sep; 33(9):947-52. PubMed ID: 21951795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene expression in osteoblastic cells.
    Rodan GA; Noda M
    Crit Rev Eukaryot Gene Expr; 1991; 1(2):85-98. PubMed ID: 1802105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors.
    Moll R
    Subcell Biochem; 1998; 31():205-62. PubMed ID: 9932494
    [No Abstract]   [Full Text] [Related]  

  • 47. SATB2 is a novel marker of osteoblastic differentiation and colorectal adenocarcinoma.
    Ordóñez NG
    Adv Anat Pathol; 2014 Jan; 21(1):63-7. PubMed ID: 24316906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SATB2 as an Immunohistochemical Marker for Colorectal Adenocarcinoma: A Concise Review of Benefits and Pitfalls.
    Berg KB; Schaeffer DF
    Arch Pathol Lab Med; 2017 Oct; 141(10):1428-1433. PubMed ID: 28968158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SATB1 and 2 in colorectal cancer.
    Brocato J; Costa M
    Carcinogenesis; 2015 Feb; 36(2):186-91. PubMed ID: 25543122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous Osteoblastic Osteosarcoma: Report of 2 New Cases Integrated With SATB2 Immunohistochemistry and Review of the Literature.
    Falconieri G; Cataldi P; Kavalar R; Štitič V; Luzar B
    Am J Dermatopathol; 2016 Nov; 38(11):824-831. PubMed ID: 27043339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of SATB2 in skeletogenesis and human disease.
    Zhao X; Qu Z; Tickner J; Xu J; Dai K; Zhang X
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):35-44. PubMed ID: 24411565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Transcription factors in tumor diagnosis].
    Moll R
    Pathologe; 2018 Dec; 39(Suppl 2):285-290. PubMed ID: 30298190
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.